TONIX PHARMACEUTICALS HLDG C - COM (TNXP)

CUSIP: 890260706

Q2 2020 13F Holders as of 30 Jun 2020

Share change
+531,027
SEC-reported price per share
$0.61
Number of holders
18
Value change
+$291,987
Number of buys
14
Number of sells
4

Security key

890260706

Report period

Q2 2020

Institutions

18

Top holders

10

Ownership snapshot

Top reported holders of TNXP - TONIX PHARMACEUTICALS HLDG C - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/11
Latest evidence
31 Mar 2020
13F Highest disclosed value: $272,000 11 rows are not safely comparable across share classes. Showing 1-6 of 11 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $272K.

0 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $272K
RENAISSANCE TECHNOLOGIES LLC $217K
CITADEL ADVISORS LLC $60K
GEODE CAPITAL MANAGEMENT, LLC $59K
NORTHERN TRUST CORP $19K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 11 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$272,000
383,084 shares
— 31 Mar 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$217,000
305,532 shares
— 31 Mar 2020
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$60,000
83,970 shares
— 31 Mar 2020
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$59,000
84,472 shares
— 31 Mar 2020
NORTHERN TRUST CORP
13F
Company
13F
—
denominator unverified
$19,000
26,714 shares
— 31 Mar 2020
HighTower Advisors, LLC
13F
Company
13F
—
denominator unverified
$15,000
21,335 shares
— 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
18
Shares
1,485,396
Rows available
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
11
Q2 2020 holders
18
Holder diff
7
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .